Voloridge Investment Management LLC Purchases 552,066 Shares of Progyny, Inc. (NASDAQ:PGNY)

Voloridge Investment Management LLC boosted its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 85.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,197,993 shares of the company's stock after buying an additional 552,066 shares during the quarter. Voloridge Investment Management LLC owned approximately 1.41% of Progyny worth $20,665,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Two Sigma Advisers LP grew its holdings in shares of Progyny by 83.8% during the fourth quarter. Two Sigma Advisers LP now owns 266,100 shares of the company's stock worth $4,590,000 after purchasing an additional 121,300 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of Progyny by 15.9% during the fourth quarter. Two Sigma Investments LP now owns 657,276 shares of the company's stock worth $11,338,000 after purchasing an additional 90,197 shares during the last quarter. State of Wyoming grew its holdings in shares of Progyny by 98.2% during the fourth quarter. State of Wyoming now owns 12,376 shares of the company's stock worth $213,000 after purchasing an additional 6,132 shares during the last quarter. ProShare Advisors LLC grew its holdings in shares of Progyny by 36.0% during the fourth quarter. ProShare Advisors LLC now owns 23,800 shares of the company's stock worth $411,000 after purchasing an additional 6,299 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Progyny by 38.4% during the fourth quarter. Nuveen Asset Management LLC now owns 295,979 shares of the company's stock worth $5,106,000 after purchasing an additional 82,087 shares during the last quarter. 94.93% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on PGNY shares. JPMorgan Chase & Co. boosted their price target on Progyny from $17.00 to $23.00 and gave the stock a "neutral" rating in a report on Tuesday, January 28th. BTIG Research raised Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective on the stock in a research note on Monday, March 31st. Bank of America lifted their price objective on Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. Finally, Canaccord Genuity Group cut their price objective on Progyny from $23.00 to $21.00 and set a "hold" rating on the stock in a research note on Monday, May 12th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $23.45.

Progyny Stock Up 0.6%

PGNY traded up $0.12 during trading on Wednesday, hitting $20.71. The company's stock had a trading volume of 242,659 shares, compared to its average volume of 1,704,571. Progyny, Inc. has a twelve month low of $13.39 and a twelve month high of $30.42. The stock's fifty day moving average price is $22.11 and its 200-day moving average price is $20.01. The firm has a market capitalization of $1.78 billion, a P/E ratio of 35.72, a PEG ratio of 2.39 and a beta of 1.37.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The business had revenue of $324.04 million during the quarter, compared to analyst estimates of $307.86 million. During the same period last year, the firm posted $0.17 earnings per share. Progyny's quarterly revenue was up 16.5% compared to the same quarter last year. Equities research analysts expect that Progyny, Inc. will post 0.6 EPS for the current fiscal year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.